EDIT:NASDAQ
Editas Medicine Inc
US$2.17
arrow_upward
+1.40%(+0.030) 1D
ኖቬም 13, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$2.14
High
US$2.21
Low
US$2.01
Mkt. cap
334.92 ሚ
Avg. vol.
2.42 ሚ
Volume
2.79 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.62
Beta
2.09
Shares outstanding
154.34 ሚ
No. of employees
87
Open
US$2.14
High
US$2.21
Low
US$2.01
Mkt. cap
334.92 ሚ
Avg. vol.
2.42 ሚ
Volume
2.79 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.62
Beta
2.09
Shares outstanding
154.34 ሚ
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
ከ10 ሰዓቶች በፊት
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Benzinga
·
ከ3 ሰዓቶች በፊት
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
The Motley Fool
·
ከ5 ሰዓቶች በፊት
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
ከ7 ሰዓቶች በፊት
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedኖቬም 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com